Making decisions about implantable cardioverter-defibrillators from implantation to end of life: An integrative review of patients' perspectives

Patient

Volumn 7, Issue 3, 2014, Pages 243-260

  Lewis, Krystina B ^a,b   Stacey, Dawn ^a,c   Matlock, Dan D ^d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSULTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; LIVING WILL; META ANALYSIS; PATIENT ATTITUDE; PATIENT DECISION MAKING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; TERMINAL CARE;

DECISION MAKING; DEFIBRILLATORS, IMPLANTABLE; FAMILY; HUMANS; PATIENT PARTICIPATION; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84906936774     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-014-0055-2     Document Type: Review

References (60)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. (Pubitemid 40110811)
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83. (Pubitemid 34984635)
3. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071-8.
4. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1-62.
5. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, et al. Predictors of short-term complications after implantable cardioverter- defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4:136-42.
6. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010;21:786-90.
7. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter- defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553-61.
8. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-65. (Pubitemid 351443082)
9. Kapa S, Rotondi-Trevisan D, Mariano Z, Aves T, Irvine J, Dorian P, et al. Psychopathology in patients with ICDs over time: results of a prospective study. Pacing Clin Electrophysiol. 2010;33:198-208.
10. Sears SF Jr, Conti JB, Curtis AB, Saia TL, Foote R, Wen F. Affective distress and implantable cardioverter defibrillators: cases for psychological and behavioral interventions. Pacing Clin Electrophysiol. 1999;22:1831-4. (Pubitemid 30027538)
11. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835-8. (Pubitemid 39601176)
12. Nambisan V, Chao D. Dying and defibrillation: a shocking experience. Palliat Med. 2004;18:482-3. (Pubitemid 39162662)
13. Sherazi S, McNitt S, Aktas MK, Polonsky B, Shah AH, Moss AJ, et al. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Pacing Clin Electrophysiol. 2013;36:1273-9.
14. O'Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, et al. Toward the 'tipping point': decision aids and informed patient choice. Health Aff (Millwood). 2007;26:716-25.
15. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-319.
16. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.
17. Ratliff A, Angell M, Dow RW, Kuppermann M, Nease RF Jr, Fisher R, et al. What is a good decision? Eff Clin Pract. 1999;2:185-97.
18. Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146.
19. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44:681-92. (Pubitemid 27067502)
20. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651-61. (Pubitemid 29314682)
21. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA. 1996;275:152-6. (Pubitemid 126532540)
22. Government of Ontario. Health Care Consent Act. In: S.O.1996 ed, 1996:c.2-Sched. A.
23. O'Connor AM, Drake ER, Wells GA, Tugwell P, Laupacis A, Elmslie T. A survey of the decision-making needs of Canadians faced with complex health decisions. Health Expect. 2003;6:97-109. (Pubitemid 36644595)
24. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52:546-53. (Pubitemid 41686698)
25. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;33:267-79. (Pubitemid 28168092)
26. Pace R, Pluye P, Bartlett G, Macaulay AC, Salsberg J, Jagosh J, et al. Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review. Int J Nurs Stud. 2012;49:47-53.
27. Pluye P, Gagnon MP, Griffiths F, Johnson-Lafleur J. A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in Mixed Studies Reviews. Int J Nurs Stud. 2009;46:529-46.
28. Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA Intern Med. 2013;173:571-7.
29. Agard A, Lofmark R, Edvardsson N, Ekman I. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation. J Med Ethics. 2007;33:514-8.
30. Carroll SL, Strachan PH, de Laat S, Schwartz L, Arthur HM. Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expect. 2013;16:69-79.
31. Groarke J, Beirne A, Buckley U, O'Dwyer E, Sugrue D, Keelan T, et al. Deficiencies in patients' comprehension of implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 2012;35:1097-102.
32. Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R. Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med. 2013;173:377-9.
33. Fluur C, Bolse K, Stromberg A, Thylén I. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart Lung. 2013;42:202-7.
34. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, et al. "That's like an act of suicide" Patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2007;23:7-12. (Pubitemid 350295388)
35. Habal MV, Micevski V, Greenwood S, Delgado DH, Ross HJ. How aware of advanced care directives are heart failure patients, and are they using them? Can J Cardiol. 2011;27:376-81.
36. Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol. 2012;109:91-4.
37. Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010;16:106-13.
38. Strachan PH, Carroll SL, de Laat S, Schwartz L, Arthur HM. Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators. J Palliat Care. 2011;27:6-11.
39. Matlock DD, Nowels CT, Masoudi FA, Sauer WH, Bekelman DB, Main DS, et al. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34:1634-44.
40. Yuhas J, Mattocks K, Gravelin L, Remetz M, Foley J, Fazio R, et al. Patients' attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis. Pacing Clin Electrophysiol. 2012;35:1179-87.
41. Matlock DD, Nowels CT, Bekelman DB. Patient perspectives on decision making in heart failure. J Card Fail. 2010;16:823-6.
42. Kantor PB, Bullinger JM, Gal CS. Patient decision-making modes and causes: a preliminary investigation. J Am Soc Inf Sci Technol. 2012;63:1339-49.
43. Gibson DP, Kuntz KK, Levenson JL, Ellenbogen KA. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace. 2008;10:540-4. (Pubitemid 351775302)
44. Thylén I, Moser DK, Chung ML, Miller J, Fluur C, Stromberg A. Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks? IJC Heart Vessels. 2013;1:22-31.
45. Raphael CE, Koa-Wing M, Stain N, Wright I, Francis DP, Kanagaratnam P. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know? Pacing Clin Electrophysiol. 2011;34:1628-33.
46. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc. 2010;85:981-90.
47. Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011;107:1071-5.
48. Pederson SS, Chaitsing R, Szili-Torok T, Jordaens L, Theuns D. Patients' perspectives on deactivation of the implantable cardioverter-defibrillator near the end of life. Am J Cardiol. 2013;111:1443-7.
49. Kobza R, Erne P. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol. 2007;30:845-9. (Pubitemid 46955404)
50. Lewis WR, Luebke DL, Johnson NJ, Harrington MD, Costantini O, Aulisio MP. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119:892-6. (Pubitemid 44415609)
51. Berger JT, Gorski M, Cohen T. Advance health planning and treatment preferences among recipients of implantable cardioverter defibrillators: an exploratory study. J Clin Ethics. 2006;17:72-8. (Pubitemid 43643945)
52. Goldstein N, Bradley E, Zeidman J, Mehta D, Morrison RS. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009;54:371-3.
53. Matlock DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, et al. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2011;4:114-21.
54. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014:CD001431.
55. Healthwise. Heart rhythm problems: Should I get an implantable cardioverter-defibrillator (ICD)? https://www.healthwise.net/ cochranedecisionaid/Content/StdDocument.aspx?DOCHWID=abk4103.
56. Healthwise. Heart Failure: should I get an implantable cardioverter-defibrillator? 2013. https://www.healthwise.net/ cochranedecisionaid/Content/StdDocument.aspx?DOCHWID=uf9848.
57. Carroll SL, McGillion M, Stacey D, Healey JS, Browne G, Arthur HM, et al. Development and feasibility testing of decision support for patients who are candidates for an implantable defibrillator: a study protocol for a pilot randomized controlled trial. Trials. 2013;14:346.
58. Fargelin A, Schneider CE. Enough: the failure of living will. Hastings Cent Rep. 2004;34:30-42.
59. Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, et al. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012;125:2382-401.
60. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. National Academy Press; 2001.